Chargement en cours...
In silico prediction of cancer immunogens: current state of the art
Cancer kills 8 million annually worldwide. Although survival rates in prevalent cancers continue to increase, many cancers have no effective treatment, prompting the search for new and improved protocols. Immunotherapy is a new and exciting addition to the anti-cancer arsenal. The successful and acc...
Enregistré dans:
| Publié dans: | BMC Immunol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5856276/ https://ncbi.nlm.nih.gov/pubmed/29544447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12865-018-0248-x |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|